Miller Fisher syndrome (MFS) is one of the rare variants of the Guillain-Barre syndrome. Charles Miller Fisher expressed the disease to be a Guillain-Barre variant with a good prognosis, that is accompanied by ataxia, ophthalmoplegia and areflexia. While it is generally monophasic, some cases with recurrences were also reported in literature. This article presents a 73-year-old male patient who was admitted to our clinic with ataxia, ophthalmoplegia, areflexia and paresthesia. No abnormality was detected in the complete blood count, routine biochemistry, erythrocyte sedimentation rate, C-reactive protein, thyroid function tests and serum vitamin B12 and folate levels, tests for hepatitis A, B and other viral markers; brain and cervical magnetic resonance images (MRI) were also normal. Electroneurography revealed the absence of the median, ulnar, peroneal and the tibial F waves. Anti-GQ1b antibody was positive in the patient's serum. He was hospitalized with the diagnosis of MFS, and he subsequently developed tetraparesis in the following a few days, and had a relapse in the early period. Seven-day intravenous immunoglobulin (IVIG) treatment which was given to the patient after hospitalization, was repeated upon the patient's relapse on the 30th day of his admission. A partial recovery of the patient's symptoms was observed after these treatments. Although there have been studies suggesting that the prognosis of MFS is good, progression or early relapses can be seen during the course of the disease; and as in this case, the repeated IVIG treatment can affect the course of the disease positively. Therefore, it is important to keep these rare conditions in mind during followup of patients diagnosed with MFS.
Keywords: Miller Fisher Syndrome, Guillain-Barre Syndrome, Intravenous immunoglobulin
ÖzetMiller Fisher sendromu (MFS), Guillain-Barre sendromunun ender varyantlarından bir tanesidir. Charles Miller Fisher tarafından hastalığın ataksi, oftalmoparezi, arefleksi triadıyla giden iyi prognozlu bir Guillain-Barre varyantı olduğu ifade edilmiştir. Genellikle monofazik olmakla birlikte literatürde rekürrenslerle giden vakalar da bildirilmiştir. Bu yazıda kliniğimize ataksi, oftalmoparezi, arefleksi ve parestezilerle başvurup MFS tanısıyla yatırılan, takip eden birkaç gün içinde tetraparezisi gelişen ve erken dönemde relaps meydana gelen 73 yaşında bir erkek hasta sunuldu. Hastanın tam kan sayımı, rutin biyokimya, eritrosit sedimantasyon hızı, C-reaktif protein, tiroid fonksiyon testleri, serum vitamin B12 ve folat düzeyleri, Hepatit B, Hepatit C ve diğer viral belirteçlerinde anormallik yoktu, ayrıca beyin ve servikal manyetik rezonans imajları (MRI) normaldi. Elektronörografide median, ulnar, peroneal ve tibial F yanıtları elde edilemedi. Serum anti-GQ1 antikoru pozitifti. Hasta MFS tanısı ile yatırıldı, sonraki bir kaç gün içerisinde tetraparezi gelişti ve erken dönemde relaps gözlendi. Hastaya servisimize yatışının ardından verilen 7 günlük intravenöz immünglobulin (IVIG) tedavisi, yatışının 30. gününde rel...